JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1576
CALL
Occidental Petroleum
OXY
$58.3B
| $33.5M | ﹤0.01% |
678,800
-29,500
| -4% | -$1.49M |
2022 Q3
9 quarters
|
|
1577
PGIM AAA CLO ETF
PAAA
$13.9B
| $33.5M | ﹤0.01% |
655,059
+368,432
| +129% | +$18.9M |
2024 Q3
1 quarter
|
|
1578
Jones Lang LaSalle
JLL
$13.9B
| $33.5M | ﹤0.01% |
132,444
-64,261
| -33% | -$17.1M |
2013 Q2
46 quarters
|
|
1579
Hancock Whitney
HWC
$5.87B
| $33.5M | ﹤0.01% |
612,571
+60,935
| +11% | +$3.37M |
2013 Q2
46 quarters
|
|
1580
American Financial Group
AFG
$11.6B
| $33.5M | ﹤0.01% |
244,554
-88,524
| -27% | -$12.2M |
2013 Q2
46 quarters
|
|
1581
Agios Pharmaceuticals
AGIO
$1.87B
| $33.4M | ﹤0.01% |
1,015,360
-697,630
| -41% | -$32.8M |
2013 Q3
45 quarters
|
|
1582
Belden
BDC
$4.35B
| $33.2M | ﹤0.01% |
294,925
+111,952
| +61% | +$13.4M |
2013 Q2
46 quarters
|
|
1583
Molina Healthcare
MOH
$10.1B
| $33M | ﹤0.01% |
113,222
-201,892
| -64% | -$62.3M |
2013 Q2
46 quarters
|
|
1584
Equitable Holdings
EQH
$14.7B
| $32.9M | ﹤0.01% |
696,813
-211,840
| -23% | -$9.78M |
2018 Q2
26 quarters
|
|
|
NVO
1585
PUT
Novo Nordisk
NVO
$166B
| $32.9M | ﹤0.01% |
382,100
+319,100
| +507% | +$34.5M |
2024 Q2
2 quarters
|
|
1586
CALL
Capital One
COF
$120B
| $32.8M | ﹤0.01% |
183,700
+59,200
| +48% | +$10.2M |
2022 Q2
10 quarters
|
|
1587
Elbit Systems
ESLT
$33.2B
| $32.7M | ﹤0.01% |
126,687
-44,016
| -26% | -$10.3M |
2013 Q2
46 quarters
|
|
1588
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.17B
| $32.7M | ﹤0.01% |
173,463
+6,922
| +4% | +$1.35M |
2022 Q2
10 quarters
|
|
1589
PUT
Applied Materials
AMAT
$430B
| $32.7M | ﹤0.01% |
200,800
-8,400
| -4% | -$1.52M |
2018 Q4
24 quarters
|
|
1590
PUT
SLB Ltd
SLB
$74.6B
| $32.6M | ﹤0.01% |
851,400
+225,000
| +36% | +$9.45M |
2014 Q2
42 quarters
|
|
1591
FMC
FMC
$1.4B
| $32.6M | ﹤0.01% |
670,469
-993,158
| -60% | -$58M |
2013 Q2
46 quarters
|
|
1592
Legend Biotech
LEGN
$3.65B
| $32.5M | ﹤0.01% |
998,016
+634,990
| +175% | +$26.3M |
2020 Q2
18 quarters
|
|
1593
BWX Technologies
BWXT
$12.4B
| $32.4M | ﹤0.01% |
290,653
+18,382
| +7% | +$2.25M |
2013 Q2
46 quarters
|
|
1594
Acadia Healthcare
ACHC
$2.69B
| $32.4M | ﹤0.01% |
816,209
-2,310,398
| -74% | -$104M |
2013 Q2
46 quarters
|
|
1595
Urban Outfitters
URBN
$6.99B
| $32.4M | ﹤0.01% |
589,660
+157,768
| +37% | +$6.73M |
2013 Q2
46 quarters
|
|
|
CVSA
1596
Covista Inc
CVSA
$4.25B
| $32.4M | ﹤0.01% |
356,088
-31,649
| -8% | -$2.65M |
2013 Q2
46 quarters
|
|
1597
Rigetti Computing
RGTI
$5.06B
| $32.3M | ﹤0.01% |
2,117,563
+2,055,203
| +3,296% | +$7.67M |
2022 Q2
10 quarters
|
|
1598
Markel Group
MKL
$21.4B
| $32.3M | ﹤0.01% |
18,712
-6,194
| -25% | -$10.3M |
2013 Q2
46 quarters
|
|
1599
Avient
AVNT
$3.82B
| $32.3M | ﹤0.01% |
790,097
+181,476
| +30% | +$8.79M |
2015 Q4
36 quarters
|
|
1600
PUT
Procter & Gamble
PG
$339B
| $32.3M | ﹤0.01% |
192,500
-32,000
| -14% | -$5.45M |
2014 Q2
42 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.